PAROXETINE tablets — Class II drug recall D-0129-2024
Terminated recall by Golden State Medical Supply Inc., reported 2023-12-06, distributed nationwide. Failed Impurities/Degradation Specifications-Manufacturer Apotex Inc. recalling lots due to Out of specificati
| Recall number | D-0129-2024 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Golden State Medical Supply Inc., Camarillo, CA, United States |
| Recall initiated | 2023-11-10 |
| Classified | 2023-11-30 |
| Reported by FDA | 2023-12-06 |
| Terminated | 2025-03-21 |
| Distributed | Nationwide (US) |
| Quantity | 2,502 bottles |
| Reason classes | specification failure |
| NDC | 60429-0734, 60429-0734-10, 60429-0734-30, 60429-0734-90, 60429-0735, 60429-0735-10, 60429-0735-30, 60429-0735-90, 60429-0736, 60429-0736-10, 60429-0736-30, 60429-0736-90, 60429-0737, 60429-0737-10, 60429-0737-30, 60429-0737-90 |
| Expiration dates | 2024-08-31 |
Product
PAROXETINE tablets, USP, 20 mg, Packaged as a) 90-count bottle NDC 60429-735-90; b)1000-count bottle, NDC 60429-735-10; Rx Only, Manufactured by Apotex, Inc., Toronto, Ontario, Canada, M9L 1T9, Packaged by GSMS, Incorporated, Camarillo, CA 93012.
Reason for recall
Failed Impurities/Degradation Specifications-Manufacturer Apotex Inc. recalling lots due to Out of specification results for the excipient Amadori Glucose adduct of Paroxetine
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0129-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.